Abstract
Background and objectives:Chronic low-grade inflammation, commonly associated with cardiovascular diseases and risk factors, has been associated inconclusively with cognitive decline and dementia. The aim of our study was to evaluate whether low-grade inflammation, measured in midlife, is associated with a decline in cognitive performance after a 10-year follow-up. We hypothesized that low-grade inflammation, estimated by interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α) and high-sensitivity CRP (hs-CRP), is a predictor of cognitive decline in the general population.Methods:This prospective cohort study is based on a Finnish nationwide, population-based Health 2000Examination Survey, its supplemental examinations in 2000-2001 and the follow-up Health 2011Survey. Cognitive performance at baseline and at follow-up was assessed with categorical verbal fluency (VF), Word-list learning (WLL) and word-list delayed recall (WLDR). Baseline low-grade inflammation was measured with IL-6, TNF-α and hs-CRP in 2001. Associations between low-grade inflammation and cognitive performance were analyzed with multivariable linear models adjusted for age, sex, education, APOEε4 genotype, type 2 diabetes, hypertension, hypercholesterolemia, body mass index, depressive symptoms, smoking, and baseline cognition.Results:915 participants aged 45 to 74 years (median age 54, 55% women) were included in the analysis. Both higher IL-6 and TNF-α at baseline predicted poorer performance in VF and WLL at 10-year follow-up (VF: IL-6 β: -1.14, p=0.003, TNF-α β: -1.78, p=0.008; WLL: IL-6 β: -0.61, p=0.007, TNF-α β: -0.86, p=0.03). Elevated IL-6 also predicted a greater decline in VF and WLL after a 10-year follow-up (VF: β: -0.81, p=0.01; WLL: β: -0.53, p=0.008). Baseline TNF-α did not predict cognitive decline and hs-CRP did not predict cognitive performance or decline after 10-years.Discussion:Our results suggest that low-grade inflammation in midlife is an independent risk factor of poorer cognitive performance later in life. Of the studied markers IL-6 and TNF-α seem to be stronger predictors for cognitive performance and decline than hs-CRP.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. “Let's talk about sex, inflammaging, and cognition, baby”: A meta-analysis and meta-regression of 106 case-control studies on mild cognitive impairment and Alzheimer's disease;Brain, Behavior, & Immunity - Health;2024-10
2. IL-6 LEVELS AND COGNITIVE COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS SECTIONAL STUDY;Ankara Universitesi Eczacilik Fakultesi Dergisi;2024-08-06
3. Plasma IL-6 levels and their association with brain health and dementia risk: A population-based cohort study;Brain, Behavior, and Immunity;2024-08
4. Association of the oral microbiome with cognitive function among older adults: NHANES 2011–2012;The Journal of nutrition, health and aging;2024-08
5. A Multicenter Study of COPD and Cognitive Impairment: Unraveling the Interplay of Quantitative CT, Lung Function, HIF-1α, and Clinical Variables;International Journal of Chronic Obstructive Pulmonary Disease;2024-07